ketoconazole has been researched along with Fungal Lung Diseases in 122 studies
1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.
Excerpt | Relevance | Reference |
---|---|---|
"Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21)." | 9.06 | Itraconazole therapy in aspergillosis: study in 49 patients. ( Dupont, B, 1990) |
"A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out." | 9.06 | Trial of ketoconazole in non-invasive pulmonary aspergillosis. ( Faux, JA; Lane, DJ; Shale, DJ, 1987) |
"The purpose of this study was to assess the tolerance and efficacy of itraconazole in the treatment of coccidioidomycosis." | 7.68 | Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. ( Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA, 1990) |
"Sixteen patients with coccidioidomycosis were treated with itraconazole for one year." | 7.68 | Itraconazole in the treatment of coccidioidomycosis. ( Cruz, S; de Hoyos, LA; Diaz, M; Puente, R, 1991) |
"Ketoconazole (KTZ) has largely replaced amphotericin B as first-line therapy for blastomycosis." | 7.68 | Asymptomatic blastomycosis of the central nervous system with progression in patients given ketoconazole therapy: a report of two cases. ( Kaufman, L; Perlino, CA; Yancey, RW, 1991) |
"A patient with longstanding ankylosing spondylitis developed chronic necrotising pulmonary aspergillosis, which was successfully treated with itraconazole." | 7.67 | Chronic necrotising pulmonary aspergillosis treated with itraconazole. ( Cumming, D; Elliott, JA; Milne, LJ, 1989) |
"Persistent adrenal insufficiency secondary to ketoconazole therapy has not previously been documented." | 7.67 | Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy. ( Best, TR; Bussell, KL; Jenkins, JK; Murphy, FY; Nicks, SA; Vesely, DL, 1987) |
"Fluconazole was compared with ketoconazole and with amphotericin B in treatment of pulmonary histoplasmosis in immunologically intact mice and in congenitally athymic nude mice." | 7.67 | Treatment of murine histoplasmosis with UK 49,858 (fluconazole). ( Ahrens, J; Graybill, JR; Palou, E, 1986) |
"Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis." | 7.67 | Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole. ( Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA, 1989) |
"We report a patient with pulmonary blastomycosis who suffered relapse with dissemination of her disease after five months of apparent response to therapy with ketoconazole, 400 mg daily." | 7.67 | Late dissemination of pulmonary blastomycosis during ketoconazole therapy. ( George, RB; Hebert, CA; King, JW, 1989) |
"Sixty patients with coccidioidomycosis were treated with ketoconazole rather than with another antifungal agent, and their responses were evaluated in relation to the predominant site of involvement." | 7.66 | Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. ( Barbee, RA; Campbell, SC; DeFelice, R; Dodge, RR; Friedman, BA; Galgiani, JN; Lincoln, LJ; Palpant, SD; Tennican, PO; Weinberg, MG, 1982) |
"A 46-year-old man with recurrent pulmonary histoplasmosis was given oral treatment with ketoconazole (a new imidazole derivative related to miconazole) in a dose of 400 mg/day for 3 months, followed by 200 mg daily for 6 months." | 7.66 | [Oral ketoconazole therapy of a case of pulmonary histoplasmosis]. ( Zellweger, JP, 1981) |
"Twenty-one patients with chronic pulmonary coccidioidomycosis were treated with ketoconazole." | 7.66 | Ketoconazole for treatment of chronic pulmonary coccidioidomycosis. ( Catanzaro, A; Einstein, H; Friedman, PJ; Levine, B; Ross, JB; Schillaci, R, 1982) |
"Forty-seven courses of oral ketoconazole therapy administered to 46 patients with progressive coccidioidomycosis were evaluated." | 7.66 | Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. ( Stevens, DA; Stiller, RL; Sugar, AM; Williams, PL, 1983) |
"Ten patients with disseminated histoplasmosis and seven with progressive cavitary histoplasmosis were treated with ketoconazole, an imidazole derivative that is well absorbed orally and relatively nontoxic." | 7.66 | Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. ( Slama, TG, 1983) |
"Two patients with severe pulmonary blastomycosis were treated with ketoconazole." | 7.66 | Failure of ketoconazole in two patients with blastomycosis. ( Buechner, HA; Cook, EW; Thiele, JS, 1983) |
"Treatment with amphotericin B resulted in only moderate improvement of the lesions and was accompanied by considerable toxicity." | 5.28 | Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. ( Raven, EJ; van 't Wout, JW; van der Meer, JW, 1990) |
"Ketoconazole was discontinued after 12 months of chronic therapy, but 2 weeks after discontinuation, blastomycosis recurred." | 5.28 | Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. ( DeVeber, G; Hii, JH; Legault, L; Vas, SI, 1990) |
"Ketoconazole therapy was well tolerated by the dog." | 5.28 | Ketoconazole therapy in a dog with systemic cryptococcosis. ( Bachrach, A; Labato, MA; Mason, GD, 1989) |
" Because ketoconazole has in-vitro activity against Blastomyces dermatitidis, we administered this agent in a dosage of 400 mg/d to 46 patients with blastomycosis, with 43 patients receiving at least 1 month of therapy." | 5.27 | Ketoconazole therapy for endemic blastomycosis. ( Abernathy, RS; Bradsher, RW; Rice, DC, 1985) |
"Treatment with amphotericin B followed by ketoconazole was as effective as amphotericin B alone and resulted in less nephrotoxicosis ." | 5.27 | Treatment of canine blastomycosis with amphotericin B and ketoconazole. ( Edwards, DF; Legendre, AM; Selcer, BA; Stevens, R, 1984) |
"Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 5.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
"A one year study of the efficacy of the antifungal agent ketoconazole in non-invasive pulmonary aspergillosis was carried out." | 5.06 | Trial of ketoconazole in non-invasive pulmonary aspergillosis. ( Faux, JA; Lane, DJ; Shale, DJ, 1987) |
"Itraconazole, 200 to 400 mg once daily, was administered to 49 patients with different types of aspergillosis: pulmonary aspergilloma (14 patients), chronic necrotizing pulmonary aspergillosis (14), and invasive aspergillosis (21)." | 5.06 | Itraconazole therapy in aspergillosis: study in 49 patients. ( Dupont, B, 1990) |
"Prior to the development of ketoconazole, the treatment of systemic histoplasmosis and blastomycosis was limited to AMB." | 4.77 | Treatment of histoplasmosis and blastomycosis. ( Dismukes, WE; Saag, MS, 1988) |
"A 49-year-old man with disseminated histoplasmosis (pulmonary and central nervous system involvement) successfully treated with ketoconazole and fluconazole combination is reported." | 3.70 | [Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection]. ( Astoul, P; Bérard, H; Boutin, C; Cho, K; Cuguillière, A; Frenay, C, 1999) |
"Sixteen patients with coccidioidomycosis were treated with itraconazole for one year." | 3.68 | Itraconazole in the treatment of coccidioidomycosis. ( Cruz, S; de Hoyos, LA; Diaz, M; Puente, R, 1991) |
"The purpose of this study was to assess the tolerance and efficacy of itraconazole in the treatment of coccidioidomycosis." | 3.68 | Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. ( Cloud, GA; Dismukes, WE; Galgiani, JN; Graybill, JR; Stevens, DA, 1990) |
"The triazole Bay R 3783 was compared with fluconazole, itraconazole, ketoconazole, and amphotericin B in rodent models of superficial and systemic candidiasis, meningocerebral cryptococcosis, and pulmonary aspergillosis." | 3.68 | Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis. ( Hector, RF; Yee, E, 1990) |
"Ketoconazole (KTZ) has largely replaced amphotericin B as first-line therapy for blastomycosis." | 3.68 | Asymptomatic blastomycosis of the central nervous system with progression in patients given ketoconazole therapy: a report of two cases. ( Kaufman, L; Perlino, CA; Yancey, RW, 1991) |
"Fluconazole was compared with ketoconazole and with amphotericin B in treatment of pulmonary histoplasmosis in immunologically intact mice and in congenitally athymic nude mice." | 3.67 | Treatment of murine histoplasmosis with UK 49,858 (fluconazole). ( Ahrens, J; Graybill, JR; Palou, E, 1986) |
"Ketoconazole appears to be a safe drug in the treatment of chronic cavitary histoplasmosis." | 3.67 | Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole. ( Gorin, AB; Hamill, RJ; Musher, DM; Quinones, CA; Reuben, AG; Sarosi, GA, 1989) |
" Their treatment included antifungal therapy with amphotericin B and diuresis to decrease noncardiogenic pulmonary edema." | 3.67 | Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literature. ( Benowitz, BA; Jacobson, JA; Larsen, RA; Morris, AH, 1985) |
"Persistent adrenal insufficiency secondary to ketoconazole therapy has not previously been documented." | 3.67 | Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy. ( Best, TR; Bussell, KL; Jenkins, JK; Murphy, FY; Nicks, SA; Vesely, DL, 1987) |
"We report a patient with pulmonary blastomycosis who suffered relapse with dissemination of her disease after five months of apparent response to therapy with ketoconazole, 400 mg daily." | 3.67 | Late dissemination of pulmonary blastomycosis during ketoconazole therapy. ( George, RB; Hebert, CA; King, JW, 1989) |
"A patient with longstanding ankylosing spondylitis developed chronic necrotising pulmonary aspergillosis, which was successfully treated with itraconazole." | 3.67 | Chronic necrotising pulmonary aspergillosis treated with itraconazole. ( Cumming, D; Elliott, JA; Milne, LJ, 1989) |
"Ten patients with disseminated histoplasmosis and seven with progressive cavitary histoplasmosis were treated with ketoconazole, an imidazole derivative that is well absorbed orally and relatively nontoxic." | 3.66 | Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. ( Slama, TG, 1983) |
"A 46-year-old man with recurrent pulmonary histoplasmosis was given oral treatment with ketoconazole (a new imidazole derivative related to miconazole) in a dose of 400 mg/day for 3 months, followed by 200 mg daily for 6 months." | 3.66 | [Oral ketoconazole therapy of a case of pulmonary histoplasmosis]. ( Zellweger, JP, 1981) |
"Twenty-one patients with chronic pulmonary coccidioidomycosis were treated with ketoconazole." | 3.66 | Ketoconazole for treatment of chronic pulmonary coccidioidomycosis. ( Catanzaro, A; Einstein, H; Friedman, PJ; Levine, B; Ross, JB; Schillaci, R, 1982) |
"Sixty patients with coccidioidomycosis were treated with ketoconazole rather than with another antifungal agent, and their responses were evaluated in relation to the predominant site of involvement." | 3.66 | Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study. ( Barbee, RA; Campbell, SC; DeFelice, R; Dodge, RR; Friedman, BA; Galgiani, JN; Lincoln, LJ; Palpant, SD; Tennican, PO; Weinberg, MG, 1982) |
"Forty-seven courses of oral ketoconazole therapy administered to 46 patients with progressive coccidioidomycosis were evaluated." | 3.66 | Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. ( Stevens, DA; Stiller, RL; Sugar, AM; Williams, PL, 1983) |
"Two patients with severe pulmonary blastomycosis were treated with ketoconazole." | 3.66 | Failure of ketoconazole in two patients with blastomycosis. ( Buechner, HA; Cook, EW; Thiele, JS, 1983) |
" The dosage and therapeutic duration were as follows: Flu 200-400 mg daily for 1-8 weeks in 34 patients with fungal infection and 150 mg as a single dose in 30 patients with fungal vaginitis; Keto 400 mg daily for 1-8 weeks in 30 patients with fungal diseases and for 5 days in 30 patients with fungal vaginitis." | 2.68 | [Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study]. ( Liang, D; Lu, Y; Zhang, H, 1997) |
"American pulmonary histoplasmosis is a deep mycosis imported from North America caused by the inhalation of Histoplasma capsulatum." | 2.40 | [American pulmonary histoplasmosis caused by Histoplasma capsulatum]. ( Bonnet, D; Cuguillière, A; Guigay, J; Jancovici, R; L'Her, P; Le Vagueresse, R; Lonjon, T; Miltgen, J; Natali, E; Vaylet, F, 1998) |
"Ketoconazole was shown to be effective for less than overwhelming blastomycosis, but adverse effects were relatively common." | 2.40 | Therapy of blastomycosis. ( Bradsher, RW, 1997) |
"Coccidioidomycosis is a largely self-limited fungal respiratory illness." | 2.38 | Coccidioidomycosis. ( Bronnimann, DA; Galgiani, JN, 1989) |
"Blastomycosis is the least understood of the major endemic mycoses in North America." | 2.38 | Blastomycosis. ( Davies, SF; Sarosi, GA, 1989) |
" The pharmacologic profiles, mechanisms of action, pharmacokinetics, clinical indications for use, dosage recommendations, side effects, and drug interactions for these agents are presented." | 2.37 | The pharmacology of agents used in the treatment of pulmonary mycoses. ( Borgers, M; Cauwenbergh, G; Vanden Bossche, H, 1986) |
"Meningitis is a particularly serious consequence of dissemination and currently is best treated with intrathecal instillation of antifungal agents." | 2.37 | Systemic fungal infections: diagnosis and treatment. I. Coccidioidomycosis. ( Galgiani, JN; Knoper, SR, 1988) |
"Pulmonary sporotrichosis is most commonly found in males with a history of alcohol abuse who are between the ages of 30 and 60." | 2.37 | Pulmonary sporotrichosis: review of treatment and outcome. ( Opal, SM; Pluss, JL, 1986) |
"Mycotic pneumonias are common problems seen in small companion animals because of the wide environmental distribution of fungi and their use of airborne spores for reproduction." | 2.37 | Mycotic pneumonias. ( Roudebush, P, 1985) |
"Blastomycosis is a rare case." | 1.38 | [Blastomycosis in Morocco: imported mycosis]. ( Aitbenali, S; Baalal, H; Belaabidia, B; Elyazidi, AA; Essaadouni, L; Essadki, O; Jghaimi, F; Mejjati, M; Naji, Y; Oussehal, A; Rais, H, 2012) |
" Therapy consists of long-term administration of itraconazole." | 1.32 | Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina. ( Godoy, H; Reichart, PA, 2003) |
"Paracoccidioidomycosis is an endemic fungal infection in Latin America." | 1.31 | Paracoccidioidomycosis: report of 2 cases mimicking squamous cell carcinoma. ( Meneses-García, A; Morales-de la Luz, R; Mosqueda-Taylor, A; Rivera, LM, 2002) |
"Spinal cord compressions are mainly due to Pott disease." | 1.30 | [Dorsal cord compression by aspergilloma. Apropos of a case]. ( Ba, MC; Badiane, M; Badiane, SB; Gueye, EM; Gueye, M; Ndao, AK; Sakho, Y, 1997) |
"Cutaneo-pulmonary blastomycosis is weakly endemic in Tunisia." | 1.29 | [Cutaneopulmonary blastomycosis]. ( Belajouzac, C; Ben Said, M; Denguezli, M; Jarray, M; Jomaa, B; Nouira, R; Skhiri, S, 1994) |
"Treatment with amphotericin B and ketoconazole resulted in clinical improvement, clearing of chest X-rays and conversion to sero-negativity." | 1.29 | Pulmonary penicillosis marneffei: report of the first imported case in Canada. ( Black, WA; Garg, AK; Glezos, JD; Sekhon, AS; Stein, L; Wong, C, 1994) |
"Ketoconazole therapy was well tolerated by the dog." | 1.28 | Ketoconazole therapy in a dog with systemic cryptococcosis. ( Bachrach, A; Labato, MA; Mason, GD, 1989) |
"Coccidioidomycosis is a deep mycotic infection endemic to the southwestern United States." | 1.28 | Disseminated coccidioidomycosis with lung, skin and lymph node involvement: report of a case. ( Chen, CH; Hsu, YT; Perng, RP; Shih, JF, 1991) |
"Acute histoplasmosis is an infrequently recognized pulmonary disease endemic in Puerto Rico." | 1.28 | Acute histoplasmosis: a modern appraisal. ( Ramírez Rivera, J, 1989) |
"Treatment with amphotericin B resulted in only moderate improvement of the lesions and was accompanied by considerable toxicity." | 1.28 | Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease. ( Raven, EJ; van 't Wout, JW; van der Meer, JW, 1990) |
"Although blastomycosis is prevalent in the North American continent, it occurs only sporadically in Africa." | 1.28 | Blastomycosis in Africa: a new case from Tunisia. ( Benzarti, M; Garrouche, A; Hayouni, A; Jerray, M; Klabi, N, 1992) |
"Ketoconazole was discontinued after 12 months of chronic therapy, but 2 weeks after discontinuation, blastomycosis recurred." | 1.28 | Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient. ( DeVeber, G; Hii, JH; Legault, L; Vas, SI, 1990) |
"Invasive fungal infections are becoming increasingly frequent among immunocompromised patients and especially among cancer patients." | 1.27 | Treatment of mycoses in cancer patients. ( Meunier-Carpentier, F, 1983) |
"A patient with acute myeloid leukemia (AML) who developed probable aspergillosis of the lung underwent partial lobectomy prior to allogeneic bone marrow transplantation (BMT)." | 1.27 | Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung. ( Cohen, O; De Pauw, BE; De Vries, F; De Witte, T; Donnelly, JP; Schattenberg, A, 1988) |
"Fluconazole was 5-20-fold more active than ketoconazole against systemic aspergillosis and against systemic, intracranial and pulmonary cryptococcosis but was less active than amphotericin B." | 1.27 | Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice. ( Andrews, RJ; Marriott, MS; Richardson, K; Troke, PF, 1987) |
"Two cases of pulmonary eosinophilia associated with coccidioidal infections are reported." | 1.27 | Pulmonary eosinophilia in coccidioidal infections. ( Krasne, DL; Lombard, CM; Tazelaar, HD, 1987) |
"Treatment with amphotericin B followed by ketoconazole was as effective as amphotericin B alone and resulted in less nephrotoxicosis ." | 1.27 | Treatment of canine blastomycosis with amphotericin B and ketoconazole. ( Edwards, DF; Legendre, AM; Selcer, BA; Stevens, R, 1984) |
" Because ketoconazole has in-vitro activity against Blastomyces dermatitidis, we administered this agent in a dosage of 400 mg/d to 46 patients with blastomycosis, with 43 patients receiving at least 1 month of therapy." | 1.27 | Ketoconazole therapy for endemic blastomycosis. ( Abernathy, RS; Bradsher, RW; Rice, DC, 1985) |
"Of 27 patients with the acquired immunodeficiency syndrome (AIDS) in Tucson, Arizona, 7 had concurrent coccidioidomycosis." | 1.27 | Coccidioidomycosis in the acquired immunodeficiency syndrome. ( Adam, RD; Bloom, JW; Bronnimann, DA; Galgiani, JN; Habib, MP; Petersen, EA; Porter, B, 1987) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 56 (45.90) | 18.7374 |
1990's | 60 (49.18) | 18.2507 |
2000's | 4 (3.28) | 29.6817 |
2010's | 2 (1.64) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Marchiori, E | 1 |
Melo, SMD | 1 |
Vianna, FG | 1 |
Melo, BSD | 1 |
Melo, SSD | 1 |
Zanetti, G | 1 |
Rais, H | 1 |
Jghaimi, F | 1 |
Baalal, H | 1 |
Naji, Y | 1 |
Essaadouni, L | 1 |
Essadki, O | 1 |
Oussehal, A | 1 |
Mejjati, M | 1 |
Aitbenali, S | 1 |
Elyazidi, AA | 1 |
Belaabidia, B | 1 |
Meneses-García, A | 1 |
Mosqueda-Taylor, A | 1 |
Morales-de la Luz, R | 1 |
Rivera, LM | 1 |
Hernandez-Divers, SJ | 1 |
Godoy, H | 1 |
Reichart, PA | 1 |
Galgiani, JN | 7 |
Stevens, DA | 5 |
Graybill, JR | 4 |
Stevens, DL | 1 |
Tillinghast, AJ | 1 |
Levine, HB | 2 |
Hoyos, GL | 1 |
McEwen, JG | 1 |
Brummer, E | 1 |
Castañeda, E | 1 |
Restrepo, A | 2 |
Zellweger, JP | 1 |
Davidson, W | 1 |
Sarosi, GA | 3 |
Ross, JB | 2 |
Levine, B | 1 |
Catanzaro, A | 2 |
Einstein, H | 2 |
Schillaci, R | 2 |
Friedman, PJ | 2 |
DeFelice, R | 1 |
Campbell, SC | 1 |
Palpant, SD | 1 |
Friedman, BA | 1 |
Dodge, RR | 1 |
Weinberg, MG | 1 |
Lincoln, LJ | 1 |
Tennican, PO | 1 |
Barbee, RA | 1 |
Staib, F | 1 |
Mishra, SK | 1 |
Harris, LF | 1 |
Le Grand, MP | 1 |
Serio, RA | 1 |
Stiller, RL | 1 |
Williams, PL | 1 |
Sugar, AM | 1 |
Kirkland, TN | 1 |
Slama, TG | 1 |
Meunier-Carpentier, F | 1 |
Stamm, AM | 1 |
Dismukes, WE | 3 |
Scholer, HJ | 1 |
Thiele, JS | 1 |
Buechner, HA | 1 |
Cook, EW | 1 |
Cano, LE | 1 |
Tabares, AM | 1 |
Iwen, PC | 1 |
Miller, NG | 1 |
McFadden, HW | 1 |
Legendre, AM | 1 |
Selcer, BA | 1 |
Edwards, DF | 1 |
Stevens, R | 1 |
Kneale, B | 1 |
Turton, C | 1 |
Sekhon, AS | 1 |
Stein, L | 1 |
Garg, AK | 1 |
Black, WA | 1 |
Glezos, JD | 1 |
Wong, C | 1 |
Failla, PJ | 1 |
Cerise, FP | 1 |
Karam, GH | 1 |
Summer, WR | 1 |
Ahasan, HA | 1 |
Rahman, KM | 1 |
Chowdhury, MA | 1 |
Azhar, MA | 1 |
Rafiqueuddin, AK | 1 |
Nouira, R | 1 |
Denguezli, M | 1 |
Skhiri, S | 1 |
Belajouzac, C | 1 |
Ben Said, M | 1 |
Jarray, M | 1 |
Jomaa, B | 1 |
Mouy, R | 2 |
Veber, F | 1 |
Blanche, S | 1 |
Donadieu, J | 1 |
Brauner, R | 1 |
Levron, JC | 1 |
Griscelli, C | 2 |
Fischer, A | 2 |
Serneels, RA | 1 |
Marshall, GS | 1 |
Wampler, J | 1 |
Miller, D | 1 |
Adams, G | 1 |
Guleria, R | 2 |
Gupta, D | 1 |
Jindal, SK | 1 |
Breeling, JL | 1 |
Weinstein, L | 1 |
Moore, L | 1 |
Ellis, DH | 1 |
Suppiah, R | 1 |
Byard, RW | 1 |
Toogood, IR | 1 |
Holt, RI | 1 |
Kwan, JT | 1 |
Sefton, AM | 1 |
Cunningham, J | 1 |
Stolk-Engelaar, MV | 1 |
Cox, NJ | 1 |
Goldberg, SL | 1 |
Geha, DJ | 1 |
Marshall, WF | 1 |
Inwards, DJ | 1 |
Hoagland, HC | 1 |
Lortholary, O | 1 |
Meyohas, MC | 1 |
Dupont, B | 4 |
Cadranel, J | 1 |
Salmon-Ceron, D | 1 |
Peyramond, D | 1 |
Simonin, D | 1 |
Manian, FA | 1 |
Brischetto, MJ | 1 |
Kuipers, S | 1 |
Pannekoek, BJ | 1 |
Schellekens, H | 1 |
Klein, NC | 1 |
Cunha, BA | 1 |
Pande, JN | 1 |
Nappert, G | 1 |
Van Dyck, T | 1 |
Papich, M | 1 |
Chirino-Trejo, M | 1 |
Bahukova, TA | 1 |
Dobrodeeva, LK | 1 |
Bradsher, RW | 2 |
Ba, MC | 1 |
Badiane, M | 1 |
Ndao, AK | 1 |
Badiane, SB | 1 |
Sakho, Y | 1 |
Gueye, EM | 1 |
Gueye, M | 1 |
Guigay, J | 1 |
Cuguillière, A | 2 |
Miltgen, J | 1 |
Lonjon, T | 1 |
Jancovici, R | 1 |
Vaylet, F | 1 |
Natali, E | 1 |
Le Vagueresse, R | 1 |
Bonnet, D | 1 |
L'Her, P | 1 |
Zhang, H | 1 |
Lu, Y | 1 |
Liang, D | 1 |
Capone, D | 1 |
Wanke, B | 1 |
Monteiro, PC | 1 |
Lazéra, MS | 1 |
de Noronha Andrade, G | 1 |
do Valle, AC | 1 |
Moreno, AM | 1 |
Londero, AT | 1 |
Bérard, H | 1 |
Astoul, P | 1 |
Frenay, C | 1 |
Cho, K | 1 |
Boutin, C | 1 |
García, ME | 1 |
Caro, A | 1 |
Fragío, C | 1 |
Blanco, I | 1 |
Blanco, JL | 1 |
Le Conte, P | 1 |
Joly, V | 1 |
Saint-Julien, L | 1 |
Gillardin, JM | 1 |
Carbon, C | 1 |
Yeni, P | 1 |
Denning, DW | 1 |
Stepan, DE | 1 |
Blume, KG | 1 |
Kalin, M | 1 |
Burdon, JG | 1 |
Barnes, M | 2 |
Harris, A | 2 |
Shannon, D | 1 |
Azanza, JR | 1 |
Herreros, J | 1 |
López-Ocariz, A | 1 |
Catalán, M | 1 |
Walsh, M | 1 |
White, L | 1 |
Atkinson, K | 1 |
Enno, A | 1 |
Schaberg, T | 1 |
Lode, H | 1 |
Masclans, JR | 1 |
Pérez, A | 1 |
Tenorio, L | 1 |
Planas, M | 1 |
Jerray, M | 1 |
Hayouni, A | 1 |
Benzarti, M | 1 |
Klabi, N | 1 |
Garrouche, A | 1 |
Delclaux, C | 1 |
Schutz, R | 1 |
Calzolari, M | 1 |
Balloul, E | 1 |
Zango, B | 1 |
Georgiev, VS | 1 |
Ruffin, RE | 1 |
Bellamy, J | 1 |
Diaz, M | 1 |
Puente, R | 1 |
de Hoyos, LA | 1 |
Cruz, S | 1 |
Kloss, S | 1 |
Schuster, A | 1 |
Schroten, H | 1 |
Lamprecht, J | 1 |
Wahn, V | 1 |
Kamei, K | 1 |
Kohno, N | 1 |
Tabeta, H | 1 |
Honda, A | 1 |
Unno, H | 1 |
Nagao, K | 1 |
Kuriyama, T | 1 |
Yamaguchi, T | 1 |
Miyaji, M | 1 |
Campbell, JH | 1 |
Winter, JH | 1 |
Richardson, MD | 1 |
Shankland, GS | 1 |
Banham, SW | 1 |
Chen, CH | 1 |
Shih, JF | 1 |
Hsu, YT | 1 |
Perng, RP | 1 |
Burdon, J | 1 |
Yancey, RW | 1 |
Perlino, CA | 1 |
Kaufman, L | 1 |
Gueteau, N | 1 |
Darras, A | 1 |
Croxo, C | 1 |
Mulliez, P | 1 |
Milleron, B | 1 |
Roger, V | 1 |
Roux, P | 1 |
Lebreton, C | 1 |
Koeger, A | 1 |
Akoun, G | 1 |
Blomley, M | 1 |
Teare, EL | 1 |
de Belder, A | 1 |
Thway, Y | 1 |
Weston, M | 1 |
Weingardt, J | 1 |
Li, YP | 1 |
Fish, DG | 1 |
Ampel, NM | 1 |
Dols, CL | 1 |
Kelly, PC | 1 |
Johnson, CH | 1 |
Pappagianis, D | 1 |
Edwards, JE | 1 |
Wasserman, RB | 1 |
Clark, RJ | 1 |
van 't Wout, JW | 1 |
Raven, EJ | 1 |
van der Meer, JW | 1 |
Hector, RF | 1 |
Yee, E | 1 |
Cloud, GA | 1 |
Impens, N | 1 |
De Greve, J | 1 |
De Beule, K | 2 |
Meysman, M | 1 |
De Beuckelaere, S | 1 |
Schandevyl, W | 1 |
Hii, JH | 1 |
Legault, L | 1 |
DeVeber, G | 1 |
Vas, SI | 1 |
Bronnimann, DA | 2 |
Davies, SF | 1 |
Faggian, G | 1 |
Livi, U | 1 |
Bortolotti, U | 1 |
Mazzucco, A | 1 |
Stellin, G | 1 |
Chiominto, B | 1 |
Vivani, MA | 1 |
Gallucci, V | 1 |
Neijens, HJ | 1 |
Frenkel, J | 1 |
de Muinck Keizer-Schrama, SM | 1 |
Dzoljic-Danilovic, G | 1 |
Meradji, M | 1 |
van Dongen, JJ | 1 |
Elliott, JA | 1 |
Milne, LJ | 1 |
Cumming, D | 1 |
Ramírez Rivera, J | 1 |
Pitrak, DL | 1 |
Andersen, BR | 1 |
Fields, CL | 1 |
Ossorio, MA | 1 |
Roy, TM | 1 |
Mason, GD | 1 |
Labato, MA | 1 |
Bachrach, A | 1 |
Severo, LC | 1 |
Geyer, GR | 1 |
Camargo, JJ | 1 |
Porto, NS | 1 |
Negroni, R | 2 |
Finquelievich, JL | 2 |
Gosis, AS | 1 |
Viviani, MA | 1 |
Tortorano, AM | 1 |
Schattenberg, A | 1 |
De Vries, F | 1 |
De Witte, T | 1 |
Cohen, O | 1 |
Donnelly, JP | 1 |
De Pauw, BE | 1 |
De Doncker, P | 1 |
Cauwenbergh, G | 2 |
Koster, M | 1 |
Legendre, R | 1 |
Blatchford, N | 1 |
Daunas, J | 1 |
Chwetzoff, E | 1 |
Bava, AJ | 1 |
Iovannitti, C | 1 |
Hebert, CA | 1 |
King, JW | 1 |
George, RB | 1 |
Quinones, CA | 1 |
Reuben, AG | 1 |
Hamill, RJ | 1 |
Musher, DM | 1 |
Gorin, AB | 1 |
Palou, E | 1 |
Ahrens, J | 1 |
Borgers, M | 1 |
Vanden Bossche, H | 1 |
Troke, PF | 1 |
Andrews, RJ | 1 |
Marriott, MS | 1 |
Richardson, K | 1 |
Eleazer, GP | 1 |
Knoper, SR | 1 |
Iida, Y | 1 |
Maehara, K | 1 |
Okamoto, Y | 1 |
Mase, K | 1 |
Uwamori, H | 1 |
Yonezu, S | 1 |
Takeuchi, J | 1 |
Simojo, M | 1 |
Yasunaga, K | 1 |
Robert, ME | 1 |
Kauffman, CA | 1 |
Saag, MS | 1 |
Shale, DJ | 1 |
Faux, JA | 1 |
Lane, DJ | 1 |
Arrieta Blanco, FJ | 1 |
Saavedra Vallejo, MP | 1 |
Tuñön Fernández, J | 1 |
Marín Hernández, G | 1 |
Aguirre Jaca, M | 1 |
Pluss, JL | 2 |
Opal, SM | 2 |
Lombard, CM | 1 |
Tazelaar, HD | 1 |
Krasne, DL | 1 |
Tuthill, SW | 1 |
Adam, RD | 1 |
Habib, MP | 1 |
Petersen, EA | 1 |
Porter, B | 1 |
Bloom, JW | 1 |
Best, TR | 1 |
Jenkins, JK | 1 |
Murphy, FY | 1 |
Nicks, SA | 1 |
Bussell, KL | 1 |
Vesely, DL | 1 |
Bremard, C | 1 |
Huu Trong, P | 1 |
Vilmer, E | 1 |
Greene, NB | 1 |
Baughman, RP | 1 |
Kim, CK | 1 |
Roselle, GA | 1 |
Roudebush, P | 1 |
Larsen, RA | 1 |
Jacobson, JA | 1 |
Morris, AH | 1 |
Benowitz, BA | 1 |
Rice, DC | 1 |
Abernathy, RS | 1 |
22 reviews available for ketoconazole and Fungal Lung Diseases
Article | Year |
---|---|
Pulmonary histoplasmosis presenting with the reversed halo sign on high-resolution CT scan.
Topics: Adult; Animals; Antifungal Agents; Chiroptera; Environmental Exposure; Histoplasmosis; Humans; Ketoc | 2011 |
Current therapy of pulmonary and disseminated fungal diseases.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Blastomycosis; Candidiasis; Chromoblastomycosis; C | 1983 |
[Chemotherapy of aspergillus lung disease].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Drug Therapy, Combination; Flucytosine; Humans; Im | 1983 |
Treatment of coccidioidomycosis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Chronic Dis | 1993 |
New antifungal drugs for pulmonary mycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1996 |
Therapy of blastomycosis.
Topics: Amphotericin B; Antifungal Agents; Blastomycosis; Dose-Response Relationship, Drug; Humans; Itracona | 1997 |
[Exotic pulmonary mycoses].
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents; Antifungal Agents; Bla | 1998 |
[American pulmonary histoplasmosis caused by Histoplasma capsulatum].
Topics: Africa; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Asia; Australia; B | 1998 |
[Rapid increase in the incidence of respiratory aspergillosis. Improved diagnosis and more aggressive treatment for better prognosis].
Topics: Antifungal Agents; Aspergillosis; Aspergillus; Humans; Incidence; Itraconazole; Ketoconazole; Lung D | 1992 |
[Therapy of pulmonary mycoses].
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Blastomy | 1992 |
[Generalized histoplasmosis due to Histoplasma duboisii with mediastino-pulmonary infection. Cure after 15 months of treatment with ketoconazole].
Topics: Biopsy; Burkina Faso; Child; Female; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Me | 1992 |
Treatment and developmental therapeutics in aspergillosis. 2. Azoles and other antifungal drugs.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Azoles; Clotrim | 1992 |
[Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].
Topics: Antifungal Agents; Aspergillosis; Carcinoma, Bronchogenic; Humans; Itraconazole; Ketoconazole; Lung | 1990 |
North American blastomycosis.
Topics: Amphotericin B; Blastomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Radio | 1991 |
Coccidioidomycosis.
Topics: Amphotericin B; Coccidioides; Coccidioidomycosis; Humans; Immune Tolerance; Ketoconazole; Lung Disea | 1989 |
Blastomycosis.
Topics: Amphotericin B; Blastomyces; Blastomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Spore | 1989 |
The pharmacology of agents used in the treatment of pulmonary mycoses.
Topics: Amphotericin B; Antifungal Agents; Drug Interactions; Flucytosine; Humans; Itraconazole; Ketoconazol | 1986 |
Pulmonary blastomycosis: a case report and review of the literature.
Topics: Aged; Amphotericin B; Blastomyces; Blastomycosis; Female; Humans; Ketoconazole; Lung Diseases, Funga | 1988 |
Systemic fungal infections: diagnosis and treatment. I. Coccidioidomycosis.
Topics: Amphotericin B; Coccidioidomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Meningitis | 1988 |
Treatment of histoplasmosis and blastomycosis.
Topics: Amphotericin B; Blastomycosis; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal | 1988 |
Pulmonary sporotrichosis: review of treatment and outcome.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Diagnosis, Differential; Humans; Ketoconazole; | 1986 |
Mycotic pneumonias.
Topics: Amphotericin B; Animals; Aspergillosis; Blastomycosis; Cat Diseases; Cats; Coccidioidomycosis; Crypt | 1985 |
5 trials available for ketoconazole and Fungal Lung Diseases
Article | Year |
---|---|
Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease.
Topics: Administration, Oral; Aspergillosis; Child; Child, Preschool; Female; Follow-Up Studies; Granulomato | 1994 |
[Fluconazole versus ketoconazole in systemic fungal infection: a double-blind randomized study].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Double-Blind Method; Female; Fluconaz | 1997 |
Itraconazole therapy in aspergillosis: study in 49 patients.
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Chronic Disease; Drug Administration Schedule; Enceph | 1990 |
The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987).
Topics: Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Chronic Disease; Clinical Trials as Topic; | 1988 |
Trial of ketoconazole in non-invasive pulmonary aspergillosis.
Topics: Adult; Aged; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus fumigatus; Clinica | 1987 |
95 other studies available for ketoconazole and Fungal Lung Diseases
Article | Year |
---|---|
[Blastomycosis in Morocco: imported mycosis].
Topics: Adult; Blastomycosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Morocco; Radiography | 2012 |
Paracoccidioidomycosis: report of 2 cases mimicking squamous cell carcinoma.
Topics: Antifungal Agents; Carcinoma, Squamous Cell; Chronic Disease; Diagnosis, Differential; Humans; Itrac | 2002 |
Pulmonary candidiasis caused by Candida albicans in a Greek tortoise (Testudo graeca) and treatment with intrapulmonary amphotericin B.
Topics: Amphotericin B; Animals; Antifungal Agents; Candidiasis; Female; Infusions, Intralesional; Ketoconaz | 2001 |
Oral manifestations of paracoccidioidomycosis. Report of 21 cases from Argentina.
Topics: Adult; Aged; Antifungal Agents; Argentina; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases | 2003 |
Pseudallescheria boydii infections treated with ketoconazole. Clinical evaluations of seven patients and in vitro susceptibility results.
Topics: Aged; Combined Modality Therapy; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Miconazo | 1984 |
Chronic murine paracoccidioidomycosis: effect of ketoconazole on clearance of Paracoccidioides brasiliensis and immune response.
Topics: Animals; Antibodies, Fungal; Chronic Disease; Disease Models, Animal; Fungi; Hypersensitivity, Delay | 1984 |
[Oral ketoconazole therapy of a case of pulmonary histoplasmosis].
Topics: Administration, Oral; Dose-Response Relationship, Drug; Histoplasmosis; Humans; Imidazoles; Ketocona | 1981 |
Disseminated blastomycosis and coccicioidomycosis in the same patient.
Topics: Aged; Antifungal Agents; Blastomycosis; Coccidioidomycosis; Humans; Imidazoles; Ketoconazole; Lung D | 1981 |
Ketoconazole for treatment of chronic pulmonary coccidioidomycosis.
Topics: Adult; Aged; Antifungal Agents; Chronic Disease; Coccidioidomycosis; Female; Humans; Imidazoles; Ket | 1982 |
Ketoconazole treatment of nonprimary coccidioidomycosis. Evaluation of 60 patients during three years of study.
Topics: Bone Diseases; Coccidioidomycosis; Dermatomycoses; Humans; Imidazoles; Ketoconazole; Lung Diseases, | 1982 |
[Ketoconazole in the treatment of pulmonary aspergillosis and aspergilloma: mycological observations (author's transl)].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillosis, Allergic Bronchopulmonary; Aspergillus | 1982 |
Histoplasmosis in Huntsville, Alabama.
Topics: Acute Disease; Adolescent; Adult; Aged; Alabama; Amphotericin B; Bone Diseases; Chronic Disease; His | 1982 |
Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis.
Topics: Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug Evaluation; | 1983 |
Treatment of coccidioidomycosis with ketoconazole: an evaluation utilizing a new scoring system.
Topics: Antifungal Agents; Bone and Bones; Bone Diseases; Coccidioidomycosis; Complement Fixation Tests; Der | 1983 |
Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole.
Topics: Adult; Aged; Antifungal Agents; Disease Outbreaks; Drug Evaluation; Female; Histoplasmosis; Humans; | 1983 |
Treatment of mycoses in cancer patients.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis; Candidiasis, Oral; Drug Therapy, Comb | 1983 |
Failure of ketoconazole in two patients with blastomycosis.
Topics: Adolescent; Amphotericin B; Blastomycosis; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Male | 1983 |
A comparison of mycelial filtrate - and yeast lysate - paracoccidioidin in patients with paracoccidioidomycosis.
Topics: Adult; Antigens, Fungal; Coccidioidin; Female; Fungal Proteins; Histoplasmosis; Humans; Ketoconazole | 1983 |
Treatment of murine pulmonary cryptococcosis with ketoconazole and amphotericin B.
Topics: Amphotericin B; Animals; Cryptococcosis; Drug Therapy, Combination; Immunosuppression Therapy; Ketoc | 1984 |
Treatment of canine blastomycosis with amphotericin B and ketoconazole.
Topics: Amphotericin B; Animals; Blastomycosis; Dog Diseases; Dogs; Drug Therapy, Combination; Female; Ketoc | 1984 |
Bronchoscopic findings in a case of bronchopulmonary histoplasmosis.
Topics: Amphotericin B; Biopsy; Bronchoscopy; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; M | 1995 |
Pulmonary penicillosis marneffei: report of the first imported case in Canada.
Topics: Amphotericin B; Antibodies, Fungal; Antigens, Fungal; Canada; Emigration and Immigration; Female; Hu | 1994 |
Blastomycosis: pulmonary and pleural manifestations.
Topics: Adult; Amphotericin B; Blastomycosis; Child; Female; Humans; Ketoconazole; Lung Diseases, Fungal; Ma | 1995 |
Pulmonary blastomycosis.
Topics: Bangladesh; Blastomycosis; Diagnosis, Differential; Humans; Ketoconazole; Lung Diseases, Fungal; Mal | 1995 |
[Cutaneopulmonary blastomycosis].
Topics: Blastomycosis; Dermatomycoses; Hemoptysis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle | 1994 |
Pulmonary sequestration with primary blastomycosis. Failure of ketoconazole therapy after resection.
Topics: Blastomycosis; Bronchopulmonary Sequestration; Child, Preschool; Female; Humans; Ketoconazole; Lung | 1993 |
Treatment of pulmonary aspergilloma by endoscopic intracavitary instillation of ketoconazole.
Topics: Adult; Aspergillosis; Aspergillus flavus; Bronchoscopy; Humans; Instillation, Drug; Ketoconazole; Lu | 1993 |
Pulmonary sporotrichosis treated with itraconazole.
Topics: Amphotericin B; Antifungal Agents; Female; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1993 |
Complete eradication of Aspergillus fumigatus from the lung in an immunocompromised patient by oral itraconazole.
Topics: Administration, Oral; Adolescent; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; | 1993 |
Successful treatment of concomitant pulmonary nocardiosis and aspergillosis in an immunocompromised renal patient.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Cyclophosphamide; Drug Therapy, Comb | 1993 |
Successful treatment of pulmonary pseudallescheriasis with itraconazole.
Topics: Adult; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Male; Pseudallescheria | 1993 |
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazole.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Aspergillus; Bone Marrow Transplantat | 1993 |
Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Antigens, Fungal; A | 1993 |
Pulmonary infection due to Exophiala jeanselmei: successful treatment with ketoconazole.
Topics: Aged; Diabetes Mellitus, Type 2; Exophiala; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Pneum | 1993 |
[Pulmonary infection with Coccidioides immitis].
Topics: Antibodies, Fungal; Antifungal Agents; Coccidioides; Coccidioidomycosis; Humans; Ketoconazole; Lung | 1996 |
Endoscopic instillation of fungicide to treat aspergilloma.
Topics: Antifungal Agents; Aspergillosis; Bronchoscopy; Humans; Instillation, Drug; Ketoconazole; Lung Disea | 1996 |
Successful treatment of a fever associated with consistent pulmonary isolation of Scopulariopsis sp. in a mare.
Topics: Administration, Intranasal; Aerosols; Animals; Antifungal Agents; Female; Horse Diseases; Horses; Im | 1996 |
[Role of fungi belonging to the genus Candida in the etiology of nonspecific pulmonary diseases].
Topics: Adolescent; Adult; Age Distribution; Aged; Amphotericin B; Antifungal Agents; Candicidin; Candida; H | 1996 |
[Dorsal cord compression by aspergilloma. Apropos of a case].
Topics: Abscess; Adult; Antifungal Agents; Aspergillosis; Diagnosis, Differential; Discitis; Epidural Space; | 1997 |
Chronic pulmonary histoplasmosis in the State of Rio de Janeiro, Brazil.
Topics: Aged; Amphotericin B; Antifungal Agents; Brazil; Fatal Outcome; Female; Histoplasma; Histoplasmosis; | 1999 |
[Disseminated histoplasmosis caused by Histoplasma capsulatum with cerebral involvement occurring 13 years after the primary infection].
Topics: Antifungal Agents; Brain; Brain Diseases; Central Nervous System Fungal Infections; Fluconazole; His | 1999 |
A clinical case of canine mycotic pneumonia.
Topics: Animals; Antifungal Agents; Dog Diseases; Dogs; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Pne | 2001 |
Tissue distribution and antifungal effect of liposomal itraconazole in experimental cryptococcosis and pulmonary aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Brain; Cryptococcosis; Cryptococcu | 1992 |
Control of invasive pulmonary aspergillosis with oral itraconazole in a bone marrow transplant patient.
Topics: Administration, Oral; Adult; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Female; | 1992 |
Treatment of pulmonary aspergilloma with itraconazole.
Topics: Antifungal Agents; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Mycetoma | 1992 |
Treatment with itraconazole of penguins suffering from aspergillosis.
Topics: Animals; Antifungal Agents; Aspergillosis; Bird Diseases; Birds; Itraconazole; Ketoconazole; Lung Di | 1992 |
[Itraconazole++-induced neurotoxicity].
Topics: Aged; Antifungal Agents; Aspergillosis; Cerebellar Diseases; Humans; Itraconazole; Ketoconazole; Lun | 1992 |
Fungal Pseudoallescheria boydii lung infiltrates unresponsive to amphotericin B in leukaemic patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Drug Resistance, Microbial; Humans; Itraconazo | 1992 |
[The use of itraconazole in liver transplantation].
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Liver Transplantation; Lung Di | 1992 |
Blastomycosis in Africa: a new case from Tunisia.
Topics: Adult; Blastomyces; Blastomycosis; Humans; Ketoconazole; Lung; Lung Diseases, Fungal; Male; Staining | 1992 |
Itraconazole and aspergilloma.
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal | 1991 |
[Aspergillosis with involvement of the thoracic wall].
Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Pneumon | 1991 |
Itraconazole in the treatment of coccidioidomycosis.
Topics: Adult; Antifungal Agents; Coccidioidomycosis; Female; Humans; Itraconazole; Ketoconazole; Lung Disea | 1991 |
Control of proven pulmonary and suspected CNS aspergillus infection with itraconazole in a patient with chronic granulomatous disease.
Topics: Antifungal Agents; Aspergillosis; Brain Diseases; Child; Granulomatous Disease, Chronic; Humans; Itr | 1991 |
[The treatment of pulmonary aspergilloma with itraconazole].
Topics: Adult; Aged; Antifungal Agents; Aspergillosis; Drug Evaluation; Female; Humans; Itraconazole; Ketoco | 1991 |
Treatment of pulmonary aspergilloma with itraconazole.
Topics: Antibodies, Fungal; Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Female; Humans; Immunog | 1991 |
Disseminated coccidioidomycosis with lung, skin and lymph node involvement: report of a case.
Topics: Adult; Coccidioidomycosis; Combined Modality Therapy; Dermatomycoses; Humans; Ketoconazole; Lung Dis | 1991 |
Itraconazole for pulmonary mycetoma.
Topics: Antifungal Agents; Drug Administration Schedule; Female; Humans; Itraconazole; Ketoconazole; Lung Di | 1991 |
Asymptomatic blastomycosis of the central nervous system with progression in patients given ketoconazole therapy: a report of two cases.
Topics: Aged; Blastomycosis; Central Nervous System Diseases; Dermatomycoses; Humans; Ketoconazole; Lung Dis | 1991 |
[Bilateral Torulopsis glabrata pneumonia].
Topics: Candidiasis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Pneumonia; Tomography, | 1991 |
Itraconazole and anti-tuberculosis drugs.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Humans; Itraconazole; Ketoconazole; Lung Di | 1990 |
Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.
Topics: Adult; Amphotericin B; Arizona; California; Coccidioidomycosis; Dermatomycoses; Female; Follow-Up St | 1990 |
Treatment of invasive aspergillosis with itraconazole in a patient with chronic granulomatous disease.
Topics: Adolescent; Amphotericin B; Aspergillosis; Aspergillus fumigatus; Chromatography, High Pressure Liqu | 1990 |
Evaluation of Bay R 3783 in rodent models of superficial and systemic candidiasis, meningeal cryptococcosis, and pulmonary aspergillosis.
Topics: Administration, Oral; Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Crypto | 1990 |
Itraconazole treatment of coccidioidomycosis. NAIAD Mycoses Study Group.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Diseases; Coccidioidomycosis; Dermatomycoses; Drug | 1990 |
Oral treatment with itraconazole of aspergilloma in cavitary lung cancer.
Topics: Antifungal Agents; Aspergillosis; Aspergillus fumigatus; Carcinoma, Small Cell; Humans; Itraconazole | 1990 |
Successful treatment of systemic blastomycosis with high-dose ketoconazole in a renal transplant recipient.
Topics: Aged; Blastomycosis; Chronic Disease; Dermatomycoses; Humans; Ketoconazole; Kidney Transplantation; | 1990 |
Itraconazole therapy for acute invasive pulmonary aspergillosis in heart transplantation.
Topics: Acute Disease; Adult; Aspergillosis; Cyclosporins; Heart Transplantation; Humans; Itraconazole; Keto | 1989 |
Invasive Aspergillus infection in chronic granulomatous disease: treatment with itraconazole.
Topics: Adult; Antifungal Agents; Aspergillosis; Aspergillus nidulans; Granulomatous Disease, Chronic; Human | 1989 |
Chronic necrotising pulmonary aspergillosis treated with itraconazole.
Topics: Antifungal Agents; Aspergillosis; Chronic Disease; Humans; Itraconazole; Ketoconazole; Lung; Lung Di | 1989 |
Acute histoplasmosis: a modern appraisal.
Topics: Acute Disease; Adult; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Puerto Rico | 1989 |
Cerebral blastomycoma after ketoconazole therapy for respiratory tract blastomycosis.
Topics: Administration, Oral; Adult; Biopsy, Needle; Blastomycosis; Brain; Brain Diseases; Female; Humans; K | 1989 |
Empyema associated with pulmonary sporotrichosis.
Topics: Empyema; Humans; Ketoconazole; Lung Diseases, Fungal; Male; Middle Aged; Pleural Effusion; Potassium | 1989 |
Ketoconazole therapy in a dog with systemic cryptococcosis.
Topics: Animals; Chorioretinitis; Cryptococcosis; Diagnosis, Differential; Dog Diseases; Dogs; Eye Infection | 1989 |
Adiaspiromycosis treated successfully with ketoconazole.
Topics: Adult; Chrysosporium; Humans; Ketoconazole; Lung Diseases, Fungal; Male | 1989 |
[Comparative study of the efficiency of itraconazole and ketoconazole in the treatment of experimental paracoccidioidomycosis].
Topics: Animals; Drug Evaluation, Preclinical; Guinea Pigs; Itraconazole; Ketoconazole; Lung Diseases, Funga | 1987 |
[Itraconazole in the treatment of deep mycoses].
Topics: Antifungal Agents; Aspergillosis; Drug Evaluation; Humans; Itraconazole; Ketoconazole; Lung Diseases | 1987 |
Allogeneic bone marrow transplantation after partial lobectomy for aspergillosis of the lung.
Topics: Adult; Amphotericin B; Aspergillosis; Bone Marrow Transplantation; Female; Humans; Itraconazole; Ket | 1988 |
Treatment of experimental sub-acute cryptococcosis in the Wistar rat.
Topics: Amphotericin B; Animals; Antifungal Agents; Brain Diseases; Cryptococcosis; Female; Granuloma, Giant | 1988 |
Late dissemination of pulmonary blastomycosis during ketoconazole therapy.
Topics: Adult; Blastomycosis; Dermatomycoses; Female; Humans; Ketoconazole; Lung; Lung Diseases, Fungal; Rad | 1989 |
Chronic cavitary histoplasmosis. Failure of oral treatment with ketoconazole.
Topics: Administration, Oral; Amphotericin B; Histoplasmosis; Humans; Ketoconazole; Lung Diseases, Fungal; M | 1989 |
Treatment of murine histoplasmosis with UK 49,858 (fluconazole).
Topics: Animals; Antifungal Agents; Female; Fluconazole; Histoplasmosis; Ketoconazole; Lung Diseases, Fungal | 1986 |
Efficacy of fluconazole (UK-49,858) against experimental aspergillosis and cryptococcosis in mice.
Topics: Amphotericin B; Animals; Antifungal Agents; Aspergillosis; Aspergillus flavus; Aspergillus fumigatus | 1987 |
[A case of cryptococcal meningitis successfully treated by ketoconazole and amphotericin B combination therapy].
Topics: Adult; Amphotericin B; Cryptococcosis; Cryptococcus neoformans; Drug Therapy, Combination; Humans; K | 1986 |
Blastomycosis presenting as polyarticular septic arthritis.
Topics: Aged; Arthritis, Infectious; Blastomycosis; Bronchoalveolar Lavage Fluid; Diagnosis, Differential; F | 1988 |
[Efficacy of ketoconazole in the treatment of systemic candidiasis with pulmonary involvement].
Topics: Aged; Candidiasis; Humans; Ketoconazole; Lung Diseases, Fungal; Male | 1988 |
Pulmonary eosinophilia in coccidioidal infections.
Topics: Adolescent; Amphotericin B; Coccidioides; Coccidioidomycosis; Diagnosis, Differential; Female; Human | 1987 |
Disseminated blastomycosis treated with ketoconazole.
Topics: Blastomycosis; Dermatomycoses; Female; Humans; Infant, Newborn; Ketoconazole; Lung Diseases, Fungal; | 1986 |
Coccidioidomycosis in the acquired immunodeficiency syndrome.
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Arizona; Coccidioidomycosis; Humans; Keto | 1987 |
Persistent adrenal insufficiency secondary to low-dose ketoconazole therapy.
Topics: Adrenal Insufficiency; Blastomycosis; Female; Glucocorticoids; Humans; Ketoconazole; Lung Diseases, | 1987 |
[Aspergillus infection and chronic septic granulomatosis].
Topics: Adolescent; Amphotericin B; Aspergillosis; Child; Child, Preschool; Female; Granulomatous Disease, C | 1985 |
Failure of ketoconazole in an immunosuppressed patient with pulmonary blastomycosis.
Topics: Adult; Blastomycosis; Female; Humans; Immunosuppression Therapy; Ketoconazole; Kidney Transplantatio | 1985 |
An additional case of pulmonary Pseudallescheria boydii improved with ketoconazole therapy.
Topics: Aged; Female; Humans; Ketoconazole; Lung Diseases, Fungal | 1985 |
Acute respiratory failure caused by primary pulmonary coccidioidomycosis. Two case reports and a review of the literature.
Topics: Adult; Amphotericin B; Antibodies, Fungal; Coccidioidomycosis; Complement Fixation Tests; Erythema; | 1985 |
Ketoconazole therapy for endemic blastomycosis.
Topics: Adult; Aged; Blastomycosis; Endocrine System Diseases; Female; Humans; Ketoconazole; Lung Diseases, | 1985 |